Search

Your search keyword '"Zuily, Stephane"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Zuily, Stephane" Remove constraint Author: "Zuily, Stephane"
149 results on '"Zuily, Stephane"'

Search Results

3. Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV)

9. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

10. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

14. Reply

16. Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration

18. Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome

20. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

25. Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests

28. 2023 ACR/EULAR antiphospholipid syndrome classification criteria

33. Efforts to Better Characterize 'Antiphospholipid Antibody Nephropathy' for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report

34. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

35. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

43. Implication of folate deficiency in CYP2U1 loss of function

45. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease

46. Additional file 5 of Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome

47. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)

48. Implication of folate deficiency in CYP2U1 loss of function

Catalog

Books, media, physical & digital resources